Bulk Manufacturer of Controlled Substances Application: Cayman Chemical Company, 95644-95647 [2016-31285]

Download as PDF 95644 Federal Register / Vol. 81, No. 249 / Wednesday, December 28, 2016 / Notices Controlled substance Drug code Carfentanil ....................................................................................................................................................................... Tapentadol ....................................................................................................................................................................... Fentanyl ........................................................................................................................................................................... The company plans to manufacture the above-listed controlled substances in bulk for distribution to its customers. In reference to drug codes 7360 marihuana and 7370 tetrahydrocannabinols the company plans to bulk manufacture both as synthetic substances. No other activity for these drug codes is authorized for this registration. Dated: December 19, 2016. Louis J. Milione, Assistant Administrator. September 1, 2016, Cambridge Isotope Laboratories, Inc., 50 Frontage Road, Andover, Massachusetts 01810 applied to be registered as a bulk manufacturer of morphine (9300), a basic class of controlled substance listed in schedule II: The company plans to utilize small quantities of the listed controlled substance for use in product development of analytical reference standards, for distribution to its customers. Dated: December 19, 2016. Louis J. Milione, Assistant Administrator. [FR Doc. 2016–31279 Filed 12–27–16; 8:45 am] BILLING CODE 4410–09–P [FR Doc. 2016–31271 Filed 12–27–16; 8:45 am] DEPARTMENT OF JUSTICE BILLING CODE 4410–09–P [Docket No. DEA–392] DEPARTMENT OF JUSTICE Bulk Manufacturer of Controlled Substances Application: Cambridge Isotope Laboratories ACTION: [Docket No. DEA–392] Notice of application. Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.33(a) on or before February 27, 2017. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: The Attorney General has delegated her authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (‘‘Assistant Administrator’’) pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.34(a), this is notice that on DATES: sradovich on DSK3GMQ082PROD with NOTICES Drug Enforcement Administration VerDate Sep<11>2014 18:54 Dec 27, 2016 Jkt 241001 Importer of Controlled Substances Application: Wildlife Laboratories, Inc. ACTION: Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.34(a) on or before January 27, 2017. Such persons may also file a written request for a hearing on the application pursuant to 21 CFR 1301.43 on or before January 27, 2017. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: The Attorney General has delegated her PO 00000 Frm 00090 Fmt 4703 Sfmt 4703 II II II authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (‘‘Assistant Administrator’’) pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.34(a), this is notice that on September 20, 2016, Wildlife Laboratories, Inc., 1230 W. Ash Street, Suite D, Windsor, Colorado 80550–8055 applied to be registered as an importer of the following basic class of controlled substances. Controlled substance Notice of application. DATES: 9743 9780 9801 Schedule Thiafentanil ............... Drug code 9729 Schedule II The company plans to import the listed controlled substance for sale to its customers. Dated: December 20, 2016. Louis J. Milione, Assistant Administrator. [FR Doc. 2016–31272 Filed 12–27–16; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] Bulk Manufacturer of Controlled Substances Application: Cayman Chemical Company ACTION: Notice of application. Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.33(a) on or before February 27, 2017. ADDRESSES: Written comments should be sent to: Drug Enforcement DATES: E:\FR\FM\28DEN1.SGM 28DEN1 95645 Federal Register / Vol. 81, No. 249 / Wednesday, December 28, 2016 / Notices Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. The Attorney General has delegated her authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to SUPPLEMENTARY INFORMATION: exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (‘‘Assistant Administrator’’) pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.33(a), this is notice that on August 16, 2016, Cayman Chemical Company, 1180 East Ellsworth Road, Ann Arbor, Michigan 48108 applied to be registered as a bulk manufacturer of the following basic classes of controlled substances: sradovich on DSK3GMQ082PROD with NOTICES Controlled substance Drug code 3-Fluoro-N-methylcathinone (3–FMC) ..................................................................................................................... Cathinone ................................................................................................................................................................. Methcathinone ......................................................................................................................................................... 4-Fluoro-N-methylcathinone (4–FMC) ..................................................................................................................... Pentedrone (a-methylaminovalerophenone) ........................................................................................................... Mephedrone (4-Methyl-N-methylcathinone) ............................................................................................................ 4-Methyl-N-ethylcathinone (4–MEC) ....................................................................................................................... Naphyrone ............................................................................................................................................................... N-Ethylamphetamine ............................................................................................................................................... N,N-Dimethylamphetamine ...................................................................................................................................... Fenethylline .............................................................................................................................................................. Aminorex .................................................................................................................................................................. 4-Methylaminorex (cis isomer) ................................................................................................................................ Gamma Hydroxybutyric Acid ................................................................................................................................... Methaqualone .......................................................................................................................................................... Mecloqualone ........................................................................................................................................................... JWH–250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) .......................................................................................... SR–18 (Also known as RCS–8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole) ........................................ 5-Flouro-UR-144 and XLR11 [1-(5-Fluoro-pentyl)1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone ......... AB–FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ............. JWH–019 (1-Hexyl-3-(1-naphthoyl)indole) .............................................................................................................. AB–PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole- .......................................................... 3-carboxamide) ........................................................................................................................................................ THJ–2201 [1-(5-fluoropentyl)-1H-indazol-3- ............................................................................................................ yl](naphthalen-1-yl)methanone ................................................................................................................................ AB–CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)- ..................................................... 1H-indazole-3-carboxamide ..................................................................................................................................... MAB–CHMINACA (N-(1-amino-3,3dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) ADB–PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ......................... APINACA and AKB48 N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide ....................................................... JWH–081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) .......................................................................................... SR–19 (Also known as RCS–4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole ............................................................ JWH–018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) ...................................................................... JWH–122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole) ............................................................................................. UR–144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone ......................................................... JWH–073 (1-Butyl-3-(1-naphthoyl)indole) ............................................................................................................... JWH–200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) .................................................................................. AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) ............................................................................................... JWH–203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) .............................................................................................. PB–22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate) ......................................................................................... 5F–PB–22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) .................................................................... Alpha-ethyltryptamine .............................................................................................................................................. Ibogaine ................................................................................................................................................................... CP–47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) ......................................................... CP–47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) ................................... Lysergic acid diethylamide ...................................................................................................................................... 2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C–T–7) ...................................................................................... Marihuana ................................................................................................................................................................ Tetrahydrocannabinols ............................................................................................................................................ Mescaline ................................................................................................................................................................. 2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine (2C–T–2 ) .................................................................................. 3,4,5-Trimethoxyamphetamine ................................................................................................................................ 4-Bromo-2,5-dimethoxyamphetamine ...................................................................................................................... 4-Bromo-2,5-dimethoxyphenethylamine .................................................................................................................. 4-Methyl-2,5-dimethoxyamphetamine ...................................................................................................................... 2,5-Dimethoxyamphetamine .................................................................................................................................... JWH–398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole) .............................................................................................. 2,5-Dimethoxy-4-ethylamphetamine ........................................................................................................................ 3,4-Methylenedioxyamphetamine ............................................................................................................................ 5-Methoxy-3,4-methylenedioxyamphetamine .......................................................................................................... N-Hydroxy-3,4-methylenedioxyamphetamine .......................................................................................................... VerDate Sep<11>2014 18:54 Dec 27, 2016 Jkt 241001 PO 00000 Frm 00091 Fmt 4703 Sfmt 4703 E:\FR\FM\28DEN1.SGM 28DEN1 Schedule 1233 1235 1237 1238 1246 1248 1249 1258 1475 1480 1503 1585 1590 2010 2565 2572 6250 7008 7011 7012 7019 I. I. I. I. I. I. I. I. I. I. I. I. I. I. I. I. I. I. I. I. I. 7023 I. 7024 I. 7031 7032 7035 7048 7081 7104 7118 7122 7144 7173 7200 7201 7203 7222 7225 7249 7260 7297 7298 7315 7348 7360 7370 7381 7385 7390 7391 7392 7395 7396 7398 7399 7400 7401 7402 I. I. I. I. I. I. I. I. I. I. I. I. I. I. I. I. I. I. I. I. I. I. I. I. I. I. I. I. I. I. I. I. I. I. I. 95646 Federal Register / Vol. 81, No. 249 / Wednesday, December 28, 2016 / Notices sradovich on DSK3GMQ082PROD with NOTICES Controlled substance Drug code 3,4-Methylenedioxy-N-ethylamphetamine ............................................................................................................... 3,4-Methylenedioxymethamphetamine .................................................................................................................... 4-Methoxyamphetamine .......................................................................................................................................... 5-Methoxy-N–N-dimethyltryptamine ........................................................................................................................ Alpha-methyltryptamine ........................................................................................................................................... Bufotenine ................................................................................................................................................................ Diethyltryptamine ..................................................................................................................................................... Dimethyltryptamine .................................................................................................................................................. Psilocybin ................................................................................................................................................................. Psilocyn .................................................................................................................................................................... 5-Methoxy-N,N-diisopropyltryptamine ...................................................................................................................... N-Benzylpiperazine .................................................................................................................................................. 2-(2,5-Dimethoxy-4-methylphenyl) ethanamine (2C–D) .......................................................................................... 2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine (2C–E ) ............................................................................................ 2-(2,5-Dimethoxyphenyl) ethanamine (2C–H) ......................................................................................................... 2-(4-Iodo-2,5-dimethoxyphenyl) ethanamine (2C–I) ................................................................................................ 2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C–C) .......................................................................................... 2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine (2C–N) ............................................................................................ 2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine (2C–P) ..................................................................................... 2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine (2C–T–4 ) ........................................................................... MDPV (3,4-Methylenedioxypyrovalerone) ............................................................................................................... 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25B–NBOMe) ............................................ 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25C–NBOMe) ............................................ 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25I–NBOMe) ................................................. Methylone (3,4-Methylenedioxy-N-methylcathinone) .............................................................................................. Butylone ................................................................................................................................................................... Pentylone ................................................................................................................................................................. alpha-pyrrolidinopentiophenone (a-PVP) ................................................................................................................ alpha-pyrrolidinobutiophenone (a-PBP) .................................................................................................................. AM–694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole) ........................................................................................... Acetyldihydrocodeine ............................................................................................................................................... Benzylmorphine ....................................................................................................................................................... Codeine-N-oxide ...................................................................................................................................................... Desomorphine .......................................................................................................................................................... Etorphine (except HCl) ............................................................................................................................................ Codeine methylbromide ........................................................................................................................................... Dihydromorphine ...................................................................................................................................................... Heroin ...................................................................................................................................................................... Morphine-N-oxide .................................................................................................................................................... Normorphine ............................................................................................................................................................ Tilidine ...................................................................................................................................................................... Para-Fluorofentanyl ................................................................................................................................................. 3-Methylfentanyl ....................................................................................................................................................... Alpha-methylfentanyl ............................................................................................................................................... Acetyl-alpha-methylfentanyl ..................................................................................................................................... Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) ....................................................................... Butyryl Fentanyl ....................................................................................................................................................... Beta-hydroxyfentanyl ............................................................................................................................................... Beta-hydroxy-3-methylfentanyl ................................................................................................................................ 3-Methylthiofentanyl ................................................................................................................................................. Thiofentanyl ............................................................................................................................................................. Beta-hydroxythiofentanyl ......................................................................................................................................... Amphetamine ........................................................................................................................................................... Methamphetamine ................................................................................................................................................... Lisdexamfetamine .................................................................................................................................................... Phenmetrazine ......................................................................................................................................................... Methylphenidate ....................................................................................................................................................... Amobarbital .............................................................................................................................................................. Pentobarbital ............................................................................................................................................................ Secobarbital ............................................................................................................................................................. Phencyclidine ........................................................................................................................................................... Phenylacetone ......................................................................................................................................................... Cocaine .................................................................................................................................................................... Codeine .................................................................................................................................................................... Etorphine HCl .......................................................................................................................................................... Dihydrocodeine ........................................................................................................................................................ Oxycodone ............................................................................................................................................................... Hydromorphone ....................................................................................................................................................... Ecgonine .................................................................................................................................................................. Ethylmorphine .......................................................................................................................................................... Hydrocodone ............................................................................................................................................................ Levomethorphan ...................................................................................................................................................... Levorphanol ............................................................................................................................................................. Isomethadone .......................................................................................................................................................... VerDate Sep<11>2014 18:54 Dec 27, 2016 Jkt 241001 PO 00000 Frm 00092 Fmt 4703 Sfmt 4703 E:\FR\FM\28DEN1.SGM 28DEN1 7404 7405 7411 7431 7432 7433 7434 7435 7437 7438 7439 7493 7508 7509 7517 7518 7519 7521 7524 7532 7535 7536 7537 7538 7540 7541 7542 7545 7546 7694 9051 9052 9053 9055 9056 9070 9145 9200 9307 9313 9750 9812 9813 9814 9815 9821 9822 9830 9831 9833 9835 9836 1100 1105 1205 1631 1724 2125 2270 2315 7471 8501 9041 9050 9059 9120 9143 9150 9180 9190 9193 9210 9220 9226 Schedule I. I. I. I. I. I. I. I. I. I. I. I. I. I. I. I. I. I. I. I. I. I. I. I. I. I. I. I. I. I. I. I. I. I. I. I. I. I. I. I. I. I. I. I. I. I. I. I. I. I. I. I. II. II. II. II. II. II. II. II. II. II. II. II. II. II. II. II. II. II. II. II. II. II. 95647 Federal Register / Vol. 81, No. 249 / Wednesday, December 28, 2016 / Notices Controlled substance Drug code Meperidine ............................................................................................................................................................... Meperidine intermediate-B ....................................................................................................................................... Methadone ............................................................................................................................................................... Dextropropoxyphene, bulk (non-dosage forms) ...................................................................................................... Morphine .................................................................................................................................................................. Thebaine .................................................................................................................................................................. Oxymorphone .......................................................................................................................................................... Alfentanil .................................................................................................................................................................. Remifentanil ............................................................................................................................................................. Sufentanil ................................................................................................................................................................. Carfentanil ................................................................................................................................................................ Tapentadol ............................................................................................................................................................... Fentanyl ................................................................................................................................................................... The company plans to manufacture bulk controlled substances for use in product development of analytical reference standards, for distribution to its customers. Drug Enforcement Administration [Docket No. DEA–392] SUPPLEMENTARY INFORMATION: ACTION: [FR Doc. 2016–31285 Filed 12–27–16; 8:45 am] Notice of registration. Registrants listed below have applied for and been granted registration by the Drug Enforcement SUMMARY: BILLING CODE 4410–09–P Company sradovich on DSK3GMQ082PROD with NOTICES Rhodes Technologies ........................................................... Bellwyck Clinical Services .................................................... Cerilliant Corporation ............................................................ Noramco, Inc ........................................................................ Cody Laboratories, Inc ......................................................... AMRI Rensselaer, Inc .......................................................... ALMAC Clinical Services Incorp (ACSI) .............................. Fresenius Kabi USA, LLC .................................................... Akorn, Inc ............................................................................. Actavis Laboratories FL, Inc ................................................ Unither Manufacturing LLC .................................................. Cambrex Charles City .......................................................... United States Pharmacopeial Convention ........................... R & D Systems, Inc .............................................................. Catalent CTS, LLC ............................................................... VerDate Sep<11>2014 18:54 Dec 27, 2016 Jkt 241001 The companies listed below applied to be registered as importers of various basic classes of controlled substances. Information on previously published notices is listed in the table below. No comments or objections were submitted and no requests for hearing were submitted for these notices. FR docket The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the registration of the listed registrants to import the applicable basic classes of schedule I or II controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated each company’s maintenance of effective controls against diversion by inspecting and testing each company’s physical security systems, verifying each company’s compliance with state and local laws, and reviewing each company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the DEA has II. II. II. II. II. II. II. II. II. II. II. II. II. Administration (DEA) as importers of various classes of schedule I or II controlled substances. DEPARTMENT OF JUSTICE Importer of Controlled Substances Registration Dated: December 20, 2016. Louis J. Milione, Assistant Administrator. 9230 9233 9250 9273 9300 9333 9652 9737 9739 9740 9743 9780 9801 Schedule 81 81 81 81 81 81 81 81 81 81 81 81 81 81 81 FR FR FR FR FR FR FR FR FR FR FR FR FR FR FR 46956 54603 57933 57932 54602 54603 54602 54601 57935 54602 61250 63222 63220 64509 66081 Published ........................................................................ ........................................................................ ........................................................................ ........................................................................ ........................................................................ ........................................................................ ........................................................................ ........................................................................ ........................................................................ ........................................................................ ........................................................................ ........................................................................ ........................................................................ ........................................................................ ........................................................................ granted a registration as an importer for schedule I or II controlled substances to the above listed persons. Dated: December 19, 2016. Louis J. Milione, Assistant Administrator. [FR Doc. 2016–31273 Filed 12–27–16; 8:45 am] July 19, 2016. August 16, 2016. August 24, 2016. August 24, 2016. August 16, 2016. August 16, 2016. August 16, 2016. August 16, 2016. August 24, 2016. August 16, 2016. September 6, 2016. September 14, 2016. September 14, 2016. September 20, 2016. September 26, 2016. Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.33(a) on or before February 27, 2017. DATES: Drug Enforcement Administration Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. [Docket No. DEA–392] SUPPLEMENTARY INFORMATION: ADDRESSES: BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Bulk Manufacturer of Controlled Substances Application: Johnson Matthey Inc. ACTION: PO 00000 Notice of application. Frm 00093 Fmt 4703 Sfmt 4703 The Attorney General has delegated her authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with E:\FR\FM\28DEN1.SGM 28DEN1

Agencies

[Federal Register Volume 81, Number 249 (Wednesday, December 28, 2016)]
[Notices]
[Pages 95644-95647]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-31285]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Bulk Manufacturer of Controlled Substances Application: Cayman 
Chemical Company

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration in accordance with 21 CFR 
1301.33(a) on or before February 27, 2017.

ADDRESSES: Written comments should be sent to: Drug Enforcement

[[Page 95645]]

Administration, Attention: DEA Federal Register Representative/DRW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: The Attorney General has delegated her 
authority under the Controlled Substances Act to the Administrator of 
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority 
to exercise all necessary functions with respect to the promulgation 
and implementation of 21 CFR part 1301, incident to the registration of 
manufacturers, distributors, dispensers, importers, and exporters of 
controlled substances (other than final orders in connection with 
suspension, denial, or revocation of registration) has been redelegated 
to the Assistant Administrator of the DEA Diversion Control Division 
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0, 
appendix to subpart R.
    In accordance with 21 CFR 1301.33(a), this is notice that on August 
16, 2016, Cayman Chemical Company, 1180 East Ellsworth Road, Ann Arbor, 
Michigan 48108 applied to be registered as a bulk manufacturer of the 
following basic classes of controlled substances:

------------------------------------------------------------------------
          Controlled substance              Drug code        Schedule
------------------------------------------------------------------------
3-Fluoro-N-methylcathinone (3-FMC).....            1233               I
Cathinone..............................            1235               I
Methcathinone..........................            1237               I
4-Fluoro-N-methylcathinone (4-FMC).....            1238               I
Pentedrone ([alpha]-                               1246               I
 methylaminovalerophenone).............
Mephedrone (4-Methyl-N-methylcathinone)            1248               I
4-Methyl-N-ethylcathinone (4-MEC)......            1249               I
Naphyrone..............................            1258               I
N-Ethylamphetamine.....................            1475               I
N,N-Dimethylamphetamine................            1480               I
Fenethylline...........................            1503               I
Aminorex...............................            1585               I
4-Methylaminorex (cis isomer)..........            1590               I
Gamma Hydroxybutyric Acid..............            2010               I
Methaqualone...........................            2565               I
Mecloqualone...........................            2572               I
JWH-250 (1-Pentyl-3-(2-                            6250               I
 methoxyphenylacetyl) indole)..........
SR-18 (Also known as RCS-8) (1-                    7008               I
 Cyclohexylethyl-3-(2-
 methoxyphenylacetyl) indole)..........
5-Flouro-UR-144 and XLR11 [1-(5-Fluoro-            7011               I
 pentyl)1H-indol-3-yl](2,2,3,3-
 tetramethylcyclopropyl)methanone......
AB-FUBINACA (N-(1-amino-3-methyl-1-                7012               I
 oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-
 indazole-3-carboxamide)...............
JWH-019 (1-Hexyl-3-(1-naphthoyl)indole)            7019               I
AB-PINACA (N-(1-amino-3-methyl-1-                  7023               I
 oxobutan-2-yl)-1-pentyl-1H-indazole-..
3-carboxamide).........................
THJ-2201 [1-(5-fluoropentyl)-1H-indazol-           7024               I
 3-....................................
yl](naphthalen-1-yl)methanone..........
AB-CHMINACA (N-(1-amino-3-methyl-1-                7031               I
 oxobutan-2-yl)-1-(cyclohexylmethyl)-..
1H-indazole-3-carboxamide..............
MAB-CHMINACA (N-(1-amino-3,3dimethyl-1-            7032               I
 oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-
 indazole-3-carboxamide)...............
ADB-PINACA (N-(1-amino-3,3-dimethyl-1-             7035               I
 oxobutan-2-yl)-1-pentyl-1H-indazole-3-
 carboxamide)..........................
APINACA and AKB48 N-(1-Adamantyl)-1-               7048               I
 pentyl-1H-indazole-3-carboxamide......
JWH-081 (1-Pentyl-3-(1-(4-                         7081               I
 methoxynaphthoyl) indole).............
SR-19 (Also known as RCS-4) (1-Pentyl-3-           7104               I
 [(4-methoxy)-benzoyl] indole..........
JWH-018 (also known as AM678) (1-Pentyl-           7118               I
 3-(1-naphthoyl)indole)................
JWH-122 (1-Pentyl-3-(4-methyl-1-                   7122               I
 naphthoyl) indole)....................
UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-           7144               I
 tetramethylcyclopropyl)methanone......
JWH-073 (1-Butyl-3-(1-naphthoyl)indole)            7173               I
JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-             7200               I
 (1-naphthoyl)indole)..................
AM2201 (1-(5-Fluoropentyl)-3-(1-                   7201               I
 naphthoyl) indole)....................
JWH-203 (1-Pentyl-3-(2-                            7203               I
 chlorophenylacetyl) indole)...........
PB-22 (Quinolin-8-yl 1-pentyl-1H-indole-           7222               I
 3-carboxylate)........................
5F-PB-22 (Quinolin-8-yl 1-(5-                      7225               I
 fluoropentyl)-1H-indole-3-carboxylate)
Alpha-ethyltryptamine..................            7249               I
Ibogaine...............................            7260               I
CP-47,497 (5-(1,1-Dimethylheptyl)-2-               7297               I
 [(1R,3S)-3-hydroxycyclohexyl-phenol)..
CP-47,497 C8 Homologue (5-(1,1-                    7298               I
 Dimethyloctyl)-2-[(1R,3S)3-
 hydroxycyclohexyl-phenol).............
Lysergic acid diethylamide.............            7315               I
2,5-Dimethoxy-4-(n)-                               7348               I
 propylthiophenethylamine (2C-T-7).....
Marihuana..............................            7360               I
Tetrahydrocannabinols..................            7370               I
Mescaline..............................            7381               I
2-(4-Ethylthio-2,5-dimethoxyphenyl)                7385               I
 ethanamine (2C-T-2 )..................
3,4,5-Trimethoxyamphetamine............            7390               I
4-Bromo-2,5-dimethoxyamphetamine.......            7391               I
4-Bromo-2,5-dimethoxyphenethylamine....            7392               I
4-Methyl-2,5-dimethoxyamphetamine......            7395               I
2,5-Dimethoxyamphetamine...............            7396               I
JWH-398 (1-Pentyl-3-(4-chloro-1-                   7398               I
 naphthoyl) indole)....................
2,5-Dimethoxy-4-ethylamphetamine.......            7399               I
3,4-Methylenedioxyamphetamine..........            7400               I
5-Methoxy-3,4-methylenedioxyamphetamine            7401               I
N-Hydroxy-3,4-methylenedioxyamphetamine            7402               I

[[Page 95646]]

 
3,4-Methylenedioxy-N-ethylamphetamine..            7404               I
3,4-Methylenedioxymethamphetamine......            7405               I
4-Methoxyamphetamine...................            7411               I
5-Methoxy-N-N-dimethyltryptamine.......            7431               I
Alpha-methyltryptamine.................            7432               I
Bufotenine.............................            7433               I
Diethyltryptamine......................            7434               I
Dimethyltryptamine.....................            7435               I
Psilocybin.............................            7437               I
Psilocyn...............................            7438               I
5-Methoxy-N,N-diisopropyltryptamine....            7439               I
N-Benzylpiperazine.....................            7493               I
2-(2,5-Dimethoxy-4-methylphenyl)                   7508               I
 ethanamine (2C-D).....................
2-(2,5-Dimethoxy-4-ethylphenyl)                    7509               I
 ethanamine (2C-E )....................
2-(2,5-Dimethoxyphenyl) ethanamine (2C-            7517               I
 H)....................................
2-(4-Iodo-2,5-dimethoxyphenyl)                     7518               I
 ethanamine (2C-I).....................
2-(4-Chloro-2,5-dimethoxyphenyl)                   7519               I
 ethanamine (2C-C).....................
2-(2,5-Dimethoxy-4-nitro-phenyl)                   7521               I
 ethanamine (2C-N).....................
2-(2,5-Dimethoxy-4-(n)-propylphenyl)               7524               I
 ethanamine (2C-P).....................
2-(4-Isopropylthio)-2,5-                           7532               I
 dimethoxyphenyl) ethanamine (2C-T-4 ).
MDPV (3,4-Methylenedioxypyrovalerone)..            7535               I
2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-              7536               I
 methoxybenzyl) ethanamine (25B-NBOMe).
2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-             7537               I
 methoxybenzyl) ethanamine (25C-NBOMe).
2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-               7538               I
 methoxybenzyl) ethanamine (25I-NBOMe).
Methylone (3,4-Methylenedioxy-N-                   7540               I
 methylcathinone)......................
Butylone...............................            7541               I
Pentylone..............................            7542               I
alpha-pyrrolidinopentiophenone ([alpha]-           7545               I
 PVP)..................................
alpha-pyrrolidinobutiophenone ([alpha]-            7546               I
 PBP)..................................
AM-694 (1-(5-Fluoropentyl)-3-(2-                   7694               I
 iodobenzoyl) indole)..................
Acetyldihydrocodeine...................            9051               I
Benzylmorphine.........................            9052               I
Codeine-N-oxide........................            9053               I
Desomorphine...........................            9055               I
Etorphine (except HCl).................            9056               I
Codeine methylbromide..................            9070               I
Dihydromorphine........................            9145               I
Heroin.................................            9200               I
Morphine-N-oxide.......................            9307               I
Normorphine............................            9313               I
Tilidine...............................            9750               I
Para-Fluorofentanyl....................            9812               I
3-Methylfentanyl.......................            9813               I
Alpha-methylfentanyl...................            9814               I
Acetyl-alpha-methylfentanyl............            9815               I
Acetyl Fentanyl (N-(1-                             9821               I
 phenethylpiperidin-4-yl)-N-
 phenylacetamide)......................
Butyryl Fentanyl.......................            9822               I
Beta-hydroxyfentanyl...................            9830               I
Beta-hydroxy-3-methylfentanyl..........            9831               I
3-Methylthiofentanyl...................            9833               I
Thiofentanyl...........................            9835               I
Beta-hydroxythiofentanyl...............            9836               I
Amphetamine............................            1100              II
Methamphetamine........................            1105              II
Lisdexamfetamine.......................            1205              II
Phenmetrazine..........................            1631              II
Methylphenidate........................            1724              II
Amobarbital............................            2125              II
Pentobarbital..........................            2270              II
Secobarbital...........................            2315              II
Phencyclidine..........................            7471              II
Phenylacetone..........................            8501              II
Cocaine................................            9041              II
Codeine................................            9050              II
Etorphine HCl..........................            9059              II
Dihydrocodeine.........................            9120              II
Oxycodone..............................            9143              II
Hydromorphone..........................            9150              II
Ecgonine...............................            9180              II
Ethylmorphine..........................            9190              II
Hydrocodone............................            9193              II
Levomethorphan.........................            9210              II
Levorphanol............................            9220              II
Isomethadone...........................            9226              II

[[Page 95647]]

 
Meperidine.............................            9230              II
Meperidine intermediate-B..............            9233              II
Methadone..............................            9250              II
Dextropropoxyphene, bulk (non-dosage               9273              II
 forms)................................
Morphine...............................            9300              II
Thebaine...............................            9333              II
Oxymorphone............................            9652              II
Alfentanil.............................            9737              II
Remifentanil...........................            9739              II
Sufentanil.............................            9740              II
Carfentanil............................            9743              II
Tapentadol.............................            9780              II
Fentanyl...............................            9801              II
------------------------------------------------------------------------

    The company plans to manufacture bulk controlled substances for use 
in product development of analytical reference standards, for 
distribution to its customers.

    Dated: December 20, 2016.
Louis J. Milione,
Assistant Administrator.
[FR Doc. 2016-31285 Filed 12-27-16; 8:45 am]
 BILLING CODE 4410-09-P